Stay updated on Trametinib and Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trametinib and Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trametinib and Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's metadata.
    Difference
    0.1%
    Check dated 2026-05-16T09:45:53.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a non-clinical site/software update.
    Difference
    0.1%
    Check dated 2026-04-24T22:25:50.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.5.2 replaces the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T14:09:36.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-20T00:18:54.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page header now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T21:36:06.000Z thumbnail image
  8. Check
    107 days ago
    Change Detected
    Summary
    This update shows a minor revision label change from v3.4.1 to v3.4.2. No substantive changes to the study details or eligibility criteria appear to have occurred.
    Difference
    0.1%
    Check dated 2026-02-12T02:23:49.000Z thumbnail image

Stay in the know with updates to Trametinib and Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trametinib and Pembrolizumab in NSCLC Clinical Trial page.